DNAPrint Genomics, Inc. Announces Relocation and Expansion
September 25, 2000, DNAPrint genomics, Inc., (Pink Sheets: "DNAP"), a Sarasota,
Florida based genomics company, announced today that it is relocating its laboratory and
offices to 900 Coconut Ave. Sarasota, FL. The Company has reached agreement for a
multi-year commitment with the owner of this property that will guarantee the company
occupancy through 2010. The new location sits on the Northwest end of the downtown
Sarasota business district where major commercial development is expanding the
gentrification of the downtown area. The Company will be specifically located across the street
from the new Renaissance development, which includes a new $100 million dollar Ritz-Carlton
luxury hotel.
The new laboratory will provide adequate space for growth and acquisition, and accommodate
new state-of-the-art equipment that is scheduled for delivery in the immediate future.
To celebrate the expansion and relocation, the Company will be hosting an Open House on
December 2, 2000 from 12 Noon to 6:00 PM. The Company will be sending formal invitations
to its investors and shareholders, and will also invite the premier Brokerage Houses,
Investment Banking Firms and Money Managers who have expressed their interest in the
Company.
In addition to a scheduled touring of the new facility, Dr. Tony Frudakis will give a presentation
detailing the Genomics industry and the Company's strategic plan. Dr. Frudakis will field
questions specific to the science and business model of the Company after the presentation.
About DNAPrint genomics
DNAPrint genomics, Inc. is developing complex genetic analytics and knowledge resources for
next generations personalized medicine. The company provides practitioners of genomic
research and personalized medicine with a comprehensive system for complex trait dissection
and patient classification. DNAPrint genomics Inc. was founded by a group of scientists with
research and commercial experience in high-level mathematical modeling, programming and
molecular genetics. For more information about the company, please visit www.dnaprint.com.
For scientific inquiries please contact: Dr. Tony Frudakis at 941/351-4543.
All other inquiries please contact: Richard Craig Hall at 941/341-0136.
Except for factual statements made herein, the information contained in this press release
consists of forward-looking statements that involve risks and uncertainties. The Company's
actual results could differ materially from those contained in such statements. Factors that
could cause or contribute to such differences include unexpected shortages of critical
components, rescheduling or cancellation of customer orders, the timing and market
acceptance of new product introductions by the Company and its competitors, and general
competition and price pressures in the marketplace.
Copyright DNAprint genomics © 2000
1748 Independence Blvd. Ste D1
Sarasota, Florida 34234
AI
